Chiroscience

Chiroscience was born from the demise of the company Enzymatix, which was ultimately acquired by Genzyme,{{Cite encyclopedia|title=Genzyme Corp|encyclopedia=International Directory of Company Histories|url=https://www.encyclopedia.com/social-sciences-and-law/economics-business-and-labor/businesses-and-occupations/genzyme-corp|date=2006|via=Encyclopedia.com}} when Andrew Richards joined the company and convinced Evans and Peter Keen to launch Chiros, which name was quickly revised to Chrioscience.{{Cite news|url=https://www.businessweekly.co.uk/news/cambridge-torchbearers/cream-life-science-entrepreneurs%E2%80%99-first-venture-was-selling-doughnuts|title=Cream of life science entrepreneurs’ first venture was selling doughnuts|last=Quested|first=Tony|date=June 7, 2015|work=Business Weekly|access-date=December 24, 2018|publisher=Q Communications|location=Cambridge, England}} Seed funding for the company of {{GBP|3 million}} was provided by Schroder Ventures, Apax and 3i. Chiroscience became one of the first biotechnology Initial Public Offerings in the United Kingdom in 1994.

In 1996, the company merged with the American biotech company Darwin Molecular Corporation, based in Cambridge, Massachusetts, retaining Chiroscience as its name.{{Cite news|url=https://www.newspapers.com/clip/26481546/chiroscience_buys_darwin/|title=Chiroscience buys Darwin|last=Springett|first=Pauline|date=November 21, 1996|work=The Guardian|access-date=December 24, 2018|page=22|via=Newspapers.com}}

By the time of its merger with Celltech in 1999,The companies were of roughly equal valuation when the merger took place. both Chris Evans and Peter Keen had left the company, leaving Andrew Richards as the sole remaining founder and member of the original management board.

• Chirocaine, an anesthetic developed by Chiroscience{{Cite news|url=https://www.newspapers.com/clip/26481112/focus_chiroscience/|title=Focus Chiroscience|last=|date=May 7, 1999|work=The Guardian|access-date=December 24, 2018|publisher=Guardian Newspapers, Ltd.|location=London, England}}{{Cite news|url=https://www.newspapers.com/clip/26482185/research_is_taming_bad_side_of_medicines/|title=Research is taming the 'bad side' of medicines|last=Choi|first=Audrey|date=November 16, 1995|work=Honolulu Star-Bulletin|access-date=December 24, 2018|agency=Originally from The Wall Street Journal|issue=274|volume=84|page=A-9}}
• Romosozumab, discovered by Chiroscience before its acquisition by Celltech
• Pharmaceutical industry in the United Kingdom

{{Reflist}}

• {{Cite news|url=https://www.newspapers.com/clip/26481241/chiroscience_on_the_up/|title=Chiroscience on the up|last=Datastream|date=May 8, 1996|work=The Guardian|access-date=December 24, 2018|location=London, England|page=21|via=Newspapers.com}} This shows performance of stock from May 1995 to May 1996.
• {{Cite news|url=https://www.newspapers.com/clip/26481425/market_report_chiroscience/|title=Market report|last=Murphy|first=Paul|date=April 26, 1996|work=The Guardian|access-date=December 24, 2018|location=London, England|page=20|quote=On Mr. Buffet's terms, Chiroscience is nothing more than a bag of dreams.|author-link=Paul Murphy (British journalist)|via=Newspapers.com}} Contains a graphic showing company stock performance across 1994 to 1996.

• [http://www.ucb-group.com/ UCB Group website] {{Webarchive|url=https://web.archive.org/web/20061004002913/http://ucb-group.com/ |date=October 4, 2006 }}

{{Pharmaceutical and biotechnology industry in the United Kingdom}}

Category:Pharmaceutical companies of the United Kingdom

{{med-company-stub}}